Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 2551-2560 of 2760 for cancer

Edit search filters
  1. A Study to Evaluate Software On Cross-sectional Imaging Evaluation of Microwave-ablated Liver Tumors

    Rochester, MN

  2. Evaluating Intestinal Microbiome and Immune Function in Lymphoma

    Rochester, MN

  3. Cardiac MRI in Patients Receiving Neoadjuvant Chemoradiotherapy for Esophageal Cancer

    Rochester, MN

  4. informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia

    Jacksonville, FL

  5. Incidence of Chemotherapy and Targeted Therapy-Related Nasal Vestibulitis

    Rochester, MN

  6. ExAblate Treatment of Metastatic Bone Tumors for the Palliation of Pain

    Rochester, MN

  7. A Study of Response Rate and Survival from Combined Chemotherapy, Surgery and Radiation Therapy for Patients with Malignant Mesothelioma

    Rochester, MN

  8. Reporting of Side Effects Among Stage III and IV Melanoma Patients Treated with Immune Checkpoint Inhibitors

    Rochester, MN

  9. A Study to Assess Older Adults Applying Pre-transplant Comorbidity, Geriatric Assessment and Biomarkers to Predict Non-Relapse Mortality After Allogeneic Transplant (CHARM)

    Rochester, MN, Scottsdale/Phoenix, AZ

  10. A Study for Germline Mutations of Patients with Phyllodes Tumors of the Breast

    Rochester, MN

.

Mayo Clinic Footer